Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention

Chun Shing Kwok, Denise Tiong, Ashish Pradhan, Andreas Y. Andreou, James Nolan, Olivier F. Bertrand, Nick Curzen, Philip Urban, Phyo K. Myint, Azfar G. Zaman, Yoon K. Loke, Mamas A. Mamas

Research output: Contribution to journalArticle

16 Citations (Scopus)
4 Downloads (Pure)

Abstract

Anemia is common amongst patients undergoing percutaneous coronary intervention (PCI) and current guidelines fail to offer recommendations for its management. This review aims to examine the relationship between baseline anemia and mortality, Major Adverse Cardiovascular Events (MACE) and major bleeding in patients undergoing PCI. We searched MEDLINE and EMBASE for studies that evaluated mortality and adverse outcomes in anemic and non-anemic patients who underwent PCI. Data were collected on study design, participant characteristics, definition of anemia, follow up and adverse outcomes. Random effects meta-analysis of risk ratios was performed using inverse variance method. A total of 44 studies were included in the review with 230,795 participants. The prevalence of baseline anemia was 26,514/170,914 (16%). There was an elevated risk of mortality and MACE with anemia compared to no anemia pooled RR 2.39 (2.02-2.83), p<0.001 and RR 1.51 (1.34-1.71), p<0.001, respectively. The risk of myocardial infarction and bleeding with anemia compared to no anemia was elevated, pooled RR 1.33 (1.07-1.65), p=0.01 and RR 1.97 (1.03-3.77), p<0.001, respectively. The risk of mortality per unit incremental decrease in hemoglobin(g/dl) was RR 1.19 (1.09-1.30), p<0.001 and the risk of mortality, MACE and re-infarction per 1 unit incremental decrease in hematocrit(%) was RR 1.07 (1.05-1.10), p=0.04, RR 1.09 (1.08-1.10) and RR 1.06 (1.03-1.10), respectively. The prevalence of anemia in contemporary cohorts of patients undergoing PCI is significant and is associated with significant increases in post procedural mortality, MACE, re-infarction and bleeding. The optimal strategy for the management of anemia in such patients remains uncertain.
Original languageEnglish
Pages (from-to)610-620
Number of pages11
JournalThe American Journal of Cardiology
Volume118
Issue number4
Early online date29 May 2016
DOIs
Publication statusPublished - 15 Aug 2016

Fingerprint

Percutaneous Coronary Intervention
Meta-Analysis
Anemia
Mortality
Hemorrhage
Infarction
Hematocrit
MEDLINE
Hemoglobins
Odds Ratio
Myocardial Infarction
Guidelines

Keywords

  • percutaneous coronary intervention
  • anemia
  • mortality

Cite this

Kwok, C. S., Tiong, D., Pradhan, A., Andreou, A. Y., Nolan, J., Bertrand, O. F., ... Mamas, M. A. (2016). Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology, 118(4), 610-620. https://doi.org/10.1016/j.amjcard.2016.05.059

Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention. / Kwok, Chun Shing; Tiong, Denise ; Pradhan, Ashish; Andreou, Andreas Y.; Nolan, James; Bertrand, Olivier F.; Curzen, Nick; Urban, Philip; Myint, Phyo K.; Zaman, Azfar G.; Loke, Yoon K.; Mamas, Mamas A.

In: The American Journal of Cardiology, Vol. 118, No. 4, 15.08.2016, p. 610-620.

Research output: Contribution to journalArticle

Kwok, CS, Tiong, D, Pradhan, A, Andreou, AY, Nolan, J, Bertrand, OF, Curzen, N, Urban, P, Myint, PK, Zaman, AG, Loke, YK & Mamas, MA 2016, 'Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention', The American Journal of Cardiology, vol. 118, no. 4, pp. 610-620. https://doi.org/10.1016/j.amjcard.2016.05.059
Kwok, Chun Shing ; Tiong, Denise ; Pradhan, Ashish ; Andreou, Andreas Y. ; Nolan, James ; Bertrand, Olivier F. ; Curzen, Nick ; Urban, Philip ; Myint, Phyo K. ; Zaman, Azfar G. ; Loke, Yoon K. ; Mamas, Mamas A. / Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention. In: The American Journal of Cardiology. 2016 ; Vol. 118, No. 4. pp. 610-620.
@article{5a5f9b1f6e1f4a06a45c8e1645b1e397,
title = "Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention",
abstract = "Anemia is common amongst patients undergoing percutaneous coronary intervention (PCI) and current guidelines fail to offer recommendations for its management. This review aims to examine the relationship between baseline anemia and mortality, Major Adverse Cardiovascular Events (MACE) and major bleeding in patients undergoing PCI. We searched MEDLINE and EMBASE for studies that evaluated mortality and adverse outcomes in anemic and non-anemic patients who underwent PCI. Data were collected on study design, participant characteristics, definition of anemia, follow up and adverse outcomes. Random effects meta-analysis of risk ratios was performed using inverse variance method. A total of 44 studies were included in the review with 230,795 participants. The prevalence of baseline anemia was 26,514/170,914 (16{\%}). There was an elevated risk of mortality and MACE with anemia compared to no anemia pooled RR 2.39 (2.02-2.83), p<0.001 and RR 1.51 (1.34-1.71), p<0.001, respectively. The risk of myocardial infarction and bleeding with anemia compared to no anemia was elevated, pooled RR 1.33 (1.07-1.65), p=0.01 and RR 1.97 (1.03-3.77), p<0.001, respectively. The risk of mortality per unit incremental decrease in hemoglobin(g/dl) was RR 1.19 (1.09-1.30), p<0.001 and the risk of mortality, MACE and re-infarction per 1 unit incremental decrease in hematocrit({\%}) was RR 1.07 (1.05-1.10), p=0.04, RR 1.09 (1.08-1.10) and RR 1.06 (1.03-1.10), respectively. The prevalence of anemia in contemporary cohorts of patients undergoing PCI is significant and is associated with significant increases in post procedural mortality, MACE, re-infarction and bleeding. The optimal strategy for the management of anemia in such patients remains uncertain.",
keywords = "percutaneous coronary intervention, anemia, mortality",
author = "Kwok, {Chun Shing} and Denise Tiong and Ashish Pradhan and Andreou, {Andreas Y.} and James Nolan and Bertrand, {Olivier F.} and Nick Curzen and Philip Urban and Myint, {Phyo K.} and Zaman, {Azfar G.} and Loke, {Yoon K.} and Mamas, {Mamas A.}",
note = "This study was funded by an award from the North Staffordshire Medical Institute, Stoke-on-Trent, United Kingdom.",
year = "2016",
month = "8",
day = "15",
doi = "10.1016/j.amjcard.2016.05.059",
language = "English",
volume = "118",
pages = "610--620",
journal = "The American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention

AU - Kwok, Chun Shing

AU - Tiong, Denise

AU - Pradhan, Ashish

AU - Andreou, Andreas Y.

AU - Nolan, James

AU - Bertrand, Olivier F.

AU - Curzen, Nick

AU - Urban, Philip

AU - Myint, Phyo K.

AU - Zaman, Azfar G.

AU - Loke, Yoon K.

AU - Mamas, Mamas A.

N1 - This study was funded by an award from the North Staffordshire Medical Institute, Stoke-on-Trent, United Kingdom.

PY - 2016/8/15

Y1 - 2016/8/15

N2 - Anemia is common amongst patients undergoing percutaneous coronary intervention (PCI) and current guidelines fail to offer recommendations for its management. This review aims to examine the relationship between baseline anemia and mortality, Major Adverse Cardiovascular Events (MACE) and major bleeding in patients undergoing PCI. We searched MEDLINE and EMBASE for studies that evaluated mortality and adverse outcomes in anemic and non-anemic patients who underwent PCI. Data were collected on study design, participant characteristics, definition of anemia, follow up and adverse outcomes. Random effects meta-analysis of risk ratios was performed using inverse variance method. A total of 44 studies were included in the review with 230,795 participants. The prevalence of baseline anemia was 26,514/170,914 (16%). There was an elevated risk of mortality and MACE with anemia compared to no anemia pooled RR 2.39 (2.02-2.83), p<0.001 and RR 1.51 (1.34-1.71), p<0.001, respectively. The risk of myocardial infarction and bleeding with anemia compared to no anemia was elevated, pooled RR 1.33 (1.07-1.65), p=0.01 and RR 1.97 (1.03-3.77), p<0.001, respectively. The risk of mortality per unit incremental decrease in hemoglobin(g/dl) was RR 1.19 (1.09-1.30), p<0.001 and the risk of mortality, MACE and re-infarction per 1 unit incremental decrease in hematocrit(%) was RR 1.07 (1.05-1.10), p=0.04, RR 1.09 (1.08-1.10) and RR 1.06 (1.03-1.10), respectively. The prevalence of anemia in contemporary cohorts of patients undergoing PCI is significant and is associated with significant increases in post procedural mortality, MACE, re-infarction and bleeding. The optimal strategy for the management of anemia in such patients remains uncertain.

AB - Anemia is common amongst patients undergoing percutaneous coronary intervention (PCI) and current guidelines fail to offer recommendations for its management. This review aims to examine the relationship between baseline anemia and mortality, Major Adverse Cardiovascular Events (MACE) and major bleeding in patients undergoing PCI. We searched MEDLINE and EMBASE for studies that evaluated mortality and adverse outcomes in anemic and non-anemic patients who underwent PCI. Data were collected on study design, participant characteristics, definition of anemia, follow up and adverse outcomes. Random effects meta-analysis of risk ratios was performed using inverse variance method. A total of 44 studies were included in the review with 230,795 participants. The prevalence of baseline anemia was 26,514/170,914 (16%). There was an elevated risk of mortality and MACE with anemia compared to no anemia pooled RR 2.39 (2.02-2.83), p<0.001 and RR 1.51 (1.34-1.71), p<0.001, respectively. The risk of myocardial infarction and bleeding with anemia compared to no anemia was elevated, pooled RR 1.33 (1.07-1.65), p=0.01 and RR 1.97 (1.03-3.77), p<0.001, respectively. The risk of mortality per unit incremental decrease in hemoglobin(g/dl) was RR 1.19 (1.09-1.30), p<0.001 and the risk of mortality, MACE and re-infarction per 1 unit incremental decrease in hematocrit(%) was RR 1.07 (1.05-1.10), p=0.04, RR 1.09 (1.08-1.10) and RR 1.06 (1.03-1.10), respectively. The prevalence of anemia in contemporary cohorts of patients undergoing PCI is significant and is associated with significant increases in post procedural mortality, MACE, re-infarction and bleeding. The optimal strategy for the management of anemia in such patients remains uncertain.

KW - percutaneous coronary intervention

KW - anemia

KW - mortality

U2 - 10.1016/j.amjcard.2016.05.059

DO - 10.1016/j.amjcard.2016.05.059

M3 - Article

VL - 118

SP - 610

EP - 620

JO - The American Journal of Cardiology

JF - The American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -